Excited to share that our latest research, titled "Exploiting epigenetic targets to overcome taxane resistance in prostate cancer," has been published in Cell Death and Disease! #ProstateCancer#Epigenetics#DrugResistance
Full article here👇
https://t.co/5zfsrOFTmr